Shares of GrafTech International plunged 8.6% to $6.50 on September 2 after JPMorgan reiterated its Underweight rating — Wall Street's way of saying "expect this stock to lag its peers" — following the company's announcement that it will permanently close its Monterrey, Mexico manufacturing facility. The sell-off caps a rough stretch: the stock has shed roughly 12.5% from its recent high of $7.43 on August 27, signaling investors see deeper trouble ahead. GrafTech Shutters Its Mexico Plant and Slashes Nearly 30% of Capacity — Is This a Turnaround Move or a White Flag?
Shares cratered 8.6% to $6.50 after GrafTech International announced the permanent closure of its Monterrey, Mexico graphite electrode plant and JPMorgan swiftly reiterated its Underweight rating — a signal the bank expects the stock to keep underperforming. With the stock down roughly 12.5% from last week's high of $7.43, the market is pricing this as a sign of distress, not discipline.
A Nearly 29% Capacity Cut Reveals How Deeply Oversupply Has Bitten
The closure will reduce GrafTech's annual graphite electrode production capacity by approximately 51,000 metric tons to 127,000 metric tons from 178,000 metric tons.
The combined capacity curtailment represents about 8% of ex-China supply.
The closure follows excess production capacity worldwide, particularly in China and India, which has outpaced demand. A company voluntarily erasing nearly a third of its footprint isn't optimizing — it's conceding the pricing environment may not recover for years.
The Savings Are Real but Modest Against a Mountain of Debt
GrafTech expects annual cash cost savings of $20 million to $25 million, excluding one-time costs, with full benefits realized in 2028.
Estimated one-time costs related to the closure are expected to total $20–25 million by the end of 2027. Meanwhile, as of June 30, 2026, the company had gross debt of $1,225 million and net debt of approximately $1,080 million. Saving $25 million a year when you owe over a billion dollars barely moves the needle.
Volume Is Growing, but the Company Can't Make Money on It
Q2 2026 sales volume grew 8% year-over-year, yet net sales were $127 million, down 3% year-over-year due to lower realized pricing, with a net loss of $40 million.
Adjusted free cash flow was negative $75 million, reflecting interest payments and an inventory build. Selling more product at worse prices while burning cash is not a sustainable formula.
Management's Spin vs. the Ground Truth CEO Timothy Flanagan called this "disciplined and decisive." But management had previously indicated the possibility of further curtailments in recent quarters — meaning this was a forced endgame, not a strategic pivot. Liquidity stands at $253 million , providing a cushion, but with no debt maturities before December 2029, the question isn't survival — it's whether shareholders see any value returned before the market eventually rebalances. JPMorgan clearly thinks the wait isn't worth it.